These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 5739758)
21. [Evaluation of the persistent action of a bronchodilator aerosol]. Hechart BB; Maña E Prensa Med Argent; 1968 Oct; 55(34):1680-3. PubMed ID: 5732958 [No Abstract] [Full Text] [Related]
22. [Clinical study of bronchodilator effects of decloxizine by intravenous route and, in increasing doses, by peroral route]. Minette A; Bruninx M Acta Tuberc Pneumol Belg; 1968; 59(4):571-82. PubMed ID: 4904306 [No Abstract] [Full Text] [Related]
23. [Protective effect of decloxizine in relation to bronchospasm due to histamine]. Mottard L; Petit JM Acta Tuberc Pneumol Belg; 1968; 59(4):749-51. PubMed ID: 5739761 [No Abstract] [Full Text] [Related]
24. [Current bronchodilating substances]. Magazanik NA Klin Med (Mosk); 1973 Jan; 51(1):135-9. PubMed ID: 4764833 [No Abstract] [Full Text] [Related]
26. The effect of a derivative of vasicine on bronchial mucus. Bruce RA; Kumar V Br J Clin Pract; 1968 Jul; 22(7):289-92. PubMed ID: 4232320 [No Abstract] [Full Text] [Related]
30. [Results obtained with bronchodilator aerosol of 1-(3,5 dehydroxyphenyl)-2-isopropylaminoethanol sulphate]. Ruiz Benítez G Rev Clin Esp; 1966 Aug; 102(4):305-10. PubMed ID: 5995634 [No Abstract] [Full Text] [Related]
31. [The role of mucolysis in the treatment of respiratory diseases]. Müller M Orv Hetil; 1971 Oct; 112(43):2593-4. PubMed ID: 5133203 [No Abstract] [Full Text] [Related]
33. [The influence of orciprenaline on the regional relationships between ventilation and perfusion in irreversible bronchial obstruction]. Stiksa J; Daum S; Nikodýmová L Arzneimittelforschung; 1967 May; 17(5):568-72. PubMed ID: 5631586 [No Abstract] [Full Text] [Related]
34. [Influence of decloxizine on various spirometric indices]. Blasi A; Di Perna A Acta Tuberc Pneumol Belg; 1968; 59(4):591-600. PubMed ID: 5739748 [No Abstract] [Full Text] [Related]
35. [Clinical testing of a bronchospasmolytic drug in retard form]. Aleksic SI Med Welt; 1975 Sep; 26(38):1733-7. PubMed ID: 1102834 [No Abstract] [Full Text] [Related]
36. Treatment of chronic obstructive bronchopulmonary disease in the aged. Lipman WH West Med Med J West; 1967; 8(3):73-5. PubMed ID: 6072167 [No Abstract] [Full Text] [Related]
37. [Ventilatory mechanics and study of a bronchodilator]. Geubelle F Acta Tuberc Pneumol Belg; 1968; 59(4):705-9. PubMed ID: 5739757 [No Abstract] [Full Text] [Related]
38. [Bronchial obstruction in complicated pulmonary hydatid disease: methods of its correction at the stage of preoperative preparation]. Ismailov DA; Sharafutdinova GKh; Pakhomov GL; Ugarova TB; Akmeev VR Probl Tuberk Bolezn Legk; 2006; (9):51-4. PubMed ID: 17128803 [No Abstract] [Full Text] [Related]
39. Synthesis and bronchodilatory activity of four new derivatives of deoxyvasicine. Ojo B; Findsen LA; Igarashi N; Kong B; Chowdhury BK Drug Des Discov; 1996 Mar; 14(1):1-14. PubMed ID: 8854041 [TBL] [Abstract][Full Text] [Related]